Logo image
Sign in
Back
Evaluation of p16 protein expression and CDKN2A deletion in conventional and fibrosarcomatous dermatofibrosarcoma protuberans
Journal article

Evaluation of p16 protein expression and CDKN2A deletion in conventional and fibrosarcomatous dermatofibrosarcoma protuberans

A. Siref, V. Patel, J. D. Reith, B. L. Balzer and W. Shon
Pathology, Vol.50(4)
2018
DOI: https://doi.org/10.1016/j.pathol.2017.11.096

Abstract

cyclin dependent kinase inhibitor 2A protein p16 CDKN2A protein, human cyclin dependent kinase inhibitor 2C tumor marker adolescent adult aged child chromosome 9 clinical article controlled study dermatofibrosarcoma protuberans female fluorescence in situ hybridization follow up gene deletion homozygosity human human tissue immunohistochemistry Letter male metastasis monosomy priority journal protein expression tissue microarray biosynthesis genetics metabolism middle aged pathology skin tumor tumor suppressor gene young adult Biomarkers, Tumor Cyclin-Dependent Kinase Inhibitor p18 Dermatofibrosarcoma Genes, p16 Humans Skin Neoplasms

Metrics

3 Record Views

Details